Human eosinophils show chemotaxis to lymphoid chemokines and exhibit antigen-presenting-cell-like properties upon stimulation with IFN-γ, IL-3 and GM-CSF

International Archives of Allergy and Immunology

Volumn 146, Issue 3, 2008, Pages 227-234

  Jung, Yun Jae ^a   Woo, So Youn ^b   Jang, Myoung Ho ^c   Miyasaka, Masayuki ^d   Ryu, Kyung Ha ^b   Park, Hae Kyung ^b   Seoh, Ju Young ^b  

^a Gachon University College of Medicine   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c OSAKA UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antigen presentation; CCL21; Chemotaxis; EoL 1 cells; Eosinophils

Indexed keywords

B7 ANTIGEN; BUCLADESINE; CCL25 CHEMOKINE; CD40 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; EOTAXIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 3; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL CULTURE; CELL LINE; CHEMOTAXIS; CONTROLLED STUDY; CULTURE MEDIUM; EOSINOPHIL; HUMAN; HUMAN CELL; LYMPH NODE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH2 CELL;

ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CHEMOTAXIS; EOSINOPHILS; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HL-60 CELLS; HUMANS; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-3; LYMPH NODES; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, VIDEO; RECEPTORS, CCR; RECEPTORS, CCR7;

EID: 45149128311     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000115891     Document Type: Article

References (29)

1. Butterworth AE: The eosinophil and its role in immunity to helminth infection. Curr Top Microbiol Immunol 1977;77:127-168.
2. Rothenberg ME, Hogan SP: The eosinophil. Annu Rev Immunol 2006;24:147-174.
3. Oehler L, Majdic O, Pickl WF, Stockl J, Riedl E, Drach J, Rappersberger K, Geissler K, Knapp W: Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics. J Exp Med 1998;187:1019-1028.
4. Duez C, Dakhama A, Tomkinson A, Marquillies P, Balhorn A, Tonnel AB, Bratton DL, Gelfand EW: Migration and accumulation of eosinophils toward regional lymph nodes after airway allergen challenge. J Allergy Clin Immunol 2004;114:820-825.
5. Shi HZ: Eosinophils function as antigen-presenting cells. J Leukoc Biol 2004;76:520-527.
6. Odemuyiwa SO, Ghahary A, Li Y, Puttagunta L, Lee JE, Musat-Marcu S, Moqbel R: Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J Immunol 2004;173:5909-5913.
7. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ: Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994;179:881-887.
8. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, Smith H, Shi X, Gonzalo JA, Newman W, Gutierrez-Ramos JC, Mackay CR: Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604-612.
9. Zimmermann N, Daugherty BL, Stark JM, Rothenberg ME: Molecular analysis of CCR-3 events in eosinophilic cells. J Immunol 2000;164:1055-1064.
10. Saito H, Bourinbaiar A, Ginsburg M, Minato K, Ceresi E, Yamada K, Machover D, Breard J, Mathe G: Establishment and characterization of a new human eosinophilic leukemia cell line. Blood 1985;66:1233-1240.
11. Mayumi M: Eol-1, a human eosinophilic cell line. Leuk Lymphoma 1992;7:243-250.
12. Saito H, Hayakawa T, Mita H, Akiyama K, Shida T: Effect of butyric acid on induction of differentiation into eosinophil-like cells in human eosinophilic leukemia cells, Eol-1 cell line: possible role of granulocyte-macrophage colony-stimulating factor as an autocrine differentiating factor. Int Arch Allergy Immunol 1993;100:240-247.
13. Wong CK, Ho CY, Lam CW, Zhang JP, Hjelm NM: Differentiation of a human eosinophilic leukemic cell line, Eol-1: characterization by the expression of cytokine receptors, adhesion molecules, CD95 and eosinophilic cationic protein (ECP). Immunol Lett 1999;68:317-323.
14. Fontana JA, Wright DG, Schiffman E, Corcoran BA, Deisseroth AB: Development of chemotactic responsiveness in myeloid precursor cells: Studies with a human leukemia cell line. Proc Natl Acad Sci USA 1980;77:3664-3668.
15. Kanegasaki S, Nomura Y, Nitta N, Akiyama S, Tamatani T, Goshoh Y, Yoshida T, Sato T, Kikuchi Y: A novel optical assay system for the quantitative measurement of chemotaxis. J Immunol Methods 2003;282:1-11.
16. Breitman TR, Hemmi H, Imaizumi M: Induction by physiological agents of differentiation of the human leukemia cell line HL-60 to cells with functional characteristics. Prog Clin Biol Res 1986;226:215-233.
17. Howe RS, Fischkoff SA, Rossi RM, Lyttle CR: Chemotactic capabilities of HL-60 human myeloid leukemia cells differentiated to eosinophils. Exp Hematol 1990;18:299-303.
18. Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF: Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000;105:945-953.
19. Tai G, Eun-Young J, Yuji H, Masahiko K, Toshio H, Kenji K, Kenshi F, Mitsufumi M: Different effects of cyclic AMP and butyrate on eosinophilic differentiation, apoptosis and bcl-2 expression of a human eosinophilic leukemia cell line, Eol-1. Hematol Oncol 1996;14:181-192.
20. Uenoyama Y, Ohshima Y, Morita M, Akutagawa H, Nambu M, Kim KM, Mayumi M, Mikawa H: Dibutyryl cyclic AMP induces formyl peptide receptor expression and chemotactic responses in a human eosinophilic cell line, Eol-1. Exp Hematol 1991;19:823-828.
21. Al-Rabia MW, Blaylock MG, Sexton DW, Walsh GM: Membrane receptor-mediated apoptosis and caspase activation in the differentiated Eol-1 eosinophilic cell line. J Leukoc Biol 2004;75:1045-1055.
22. Freshney RI: Culture of Animal Cells: A Manual of Basic Techniques, ed 4. New York, Wiley-Liss, 2000.
23. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, Williams LT, Nakano H: Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999;189:451-460.
24. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT: A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 1998;95:258-263.
25. Cyster JG: Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J Exp Med 1999;189:447-450.
26. Matthews AN, Friend DS, Zimmermann N, Sarafi MN, Luster AD, Pearlman E, Wert SE, Rothenberg ME: Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci USA 1998;95:6273-6278.
27. Rothenberg ME, Luster AD, Leder P: Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 1995;92:8960-8964.
28. Lucey DR, Nicholson-Weller A, Weller PF: Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci USA 1989;86:1348-1351.
29. Weller PF, Rand TH, Barrett T, Elovic A, Wong DT, Finberg RW: Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol 1993;150:2554-2562.